Helen Coolican
Overview
Explore the profile of Helen Coolican including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
90
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rangan G, Wong A, Munt A, Zhang J, Saravanabavan S, Louw S, et al.
NEJM Evid
. 2024 Feb;
1(1):EVIDoa2100021.
PMID: 38319283
BACKGROUND: Arginine vasopressin promotes kidney cyst growth in autosomal dominant polycystic kidney disease (ADPKD). Increased water intake reduces arginine vasopressin and urine osmolality and may slow kidney cyst growth. METHODS:...
2.
Amin S, Sangadi I, Allman-Farinelli M, Badve S, Boudville N, Coolican H, et al.
Kidney Med
. 2023 Aug;
5(9):100691.
PMID: 37602144
Rationale & Objective: The development of new therapies for autosomal dominant polycystic kidney disease requires clinical trials to be conducted efficiently. In this study, the factors affecting the recruitment and...
3.
Lambert K, Gardos R, Coolican H, Pickel L, Sung H, Yee-Moon Wang A, et al.
Semin Nephrol
. 2023 Aug;
43(2):151405.
PMID: 37542985
Polycystic kidney disease (PKD) is a chronic, progressive hereditary condition characterized by abnormal development and growth of cysts in the kidneys and other organs. There is increasing interest in exploring...
4.
Wong A, Munt A, Allman-Farinelli M, Badve S, Boudville N, Coolican H, et al.
Nutrients
. 2020 Nov;
12(11).
PMID: 33147804
The excess intake of dietary sodium is a key modifiable factor for reducing disease progression in autosomal dominant polycystic kidney disease (ADPKD). The aim of this study was to test...
5.
Logeman C, Cho Y, Sautenet B, Rangan G, Gutman T, Craig J, et al.
BMJ Open
. 2020 Oct;
10(10):e038005.
PMID: 33040007
Background And Objectives: Presymptomatic testing is available for early diagnosis of hereditary autosomal dominant polycystic kidney disease (ADPKD). However, the complex ethical and psychosocial implications can make decision-making challenging and...
6.
Cho Y, Tong A, Craig J, Mustafa R, Chapman A, Perrone R, et al.
Am J Kidney Dis
. 2020 Aug;
77(2):255-263.
PMID: 32771648
The omission of outcomes that are of relevance to patients, clinicians, and regulators across trials in autosomal dominant polycystic kidney disease (ADPKD) limits shared decision making. The Standardized Outcomes in...
7.
Cho Y, Rangan G, Logeman C, Ryu H, Sautenet B, Perrone R, et al.
Am J Kidney Dis
. 2020 May;
76(3):361-373.
PMID: 32359822
Rationale & Objective: Outcomes reported in trials involving patients with autosomal dominant polycystic kidney disease (ADPKD) are heterogeneous and rarely include patient-reported outcomes. We aimed to identify critically important consensus-based...
8.
Sautenet B, Cho Y, Gutman T, Rangan G, Ong A, Chapman A, et al.
Am J Kidney Dis
. 2020 Mar;
76(2):213-223.
PMID: 32171640
Rationale & Objective: Trials in autosomal dominant polycystic kidney disease (ADPKD) have increased, but their impact on decision making has been limited. Because heterogeneity in reported outcomes may be responsible,...
9.
Cho Y, Sautenet B, Gutman T, Rangan G, Craig J, Ong A, et al.
Nephrology (Carlton)
. 2019 Jan;
24(12):1214-1224.
PMID: 30663163
Aim: Patients with autosomal dominant polycystic kidney disease (ADPKD) are at increased risk of premature mortality, morbidities and complications, which severely impair quality of life. However, patient-centered outcomes are not...
10.
Cho Y, Sautenet B, Rangan G, Craig J, Ong A, Chapman A, et al.
Trials
. 2017 Nov;
18(1):560.
PMID: 29169385
Background: Autosomal dominant polycystic kidney disease (ADPKD) is the most common potentially life threatening inherited kidney disease and is responsible for 5-10% of cases of end-stage kidney disease (ESKD). Cystic...